Arushi Pandya is an associate in the Governmental Practice and a member of the Healthcare and Life Sciences teams.
Arushi advises on regulatory, compliance, and operational matters affecting the healthcare and life sciences industries.
In her healthcare regulatory practice, Arushi provides guidance on a variety of federal and state issues including digital health and telehealth, privacy, compliance programs, licensure and scope of practice, EMTALA, fraud and abuse (including the Anti-Kickback Statute, Civil Monetary Penalties Law, and Stark Law), corporate practice of medicine, billing and reimbursement, as well as internal and governmental investigations.
In her FDA regulatory practice, Arushi assists clients with privacy and data security issues, life sciences transactions (including clinical trial and investigator agreements), state licensure issues, developing policies and procedures for comprehensive compliance programs, advertising and promotion, sampling issues, and internal investigations. She also assists pharmaceutical, biotechnology, and medical device companies comply with pre-market and post-market FDA requirements.
Arushi also advises healthcare and life sciences entities on privacy and digital health matters such as artificial intelligence, third-party web tracking, breach response, and a range of privacy and security laws, including HIPAA and other federal and state privacy laws.